3 Ways Your CDMO Can Help You Avoid Supply Chain Problems
The COVID-19 pandemic has significantly disrupted supply chains and production schedules around the world. It underscores the importance of having a robust supply chain strategy and being ahead of challenges before they arise.
Understanding the complexities of supply chain management in Good Manufacturing Practices (GMP) production of your cell and gene therapy (CGT) products can help you make an informed decision when choosing your contract development and manufacturing organization (CDMO) and avoid supply chain disruptions.
Here are three things you should ensure that your CDMO considers so that your project will stay the course.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.